Nasdaq:US$15.05 (-0.05) | HKEX:HK$23.55 (-0.20) | AIM:£2.27 (+0.08)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF